Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Prof. Mike Chan's Precision Medicine Vision Validated by Landmark Human Cytology Study Mapping Over 400 Distinct Cell Types - with Special Focus on the Brain
  • USA - español
  • Middle East - Arabic
  • USA - Français
  • APAC - Traditional Chinese
  • USA - Deutsch
  • APAC - English


News provided by

European Wellness Biomedical Group

May 12, 2025, 04:11 ET

Share this article

Share toX

Share this article

Share toX

HEIDELBERG, Germany, May 12, 2025 /PRNewswire/ -- A groundbreaking international study has mapped over 400 distinct human cell types, providing powerful validation for Prof. Mike Chan's longstanding vision of organ-specific, cell-specific regenerative medicine. This pivotal research [1], authored by Prof. Mike Chan and published by Genesis Biomedical Research Institute in collaboration with global universities, represents a transformative leap in precision healthcare, including the complex realm of brain regeneration.

Continue Reading
Prof. Mike Chan reviews a brain replica alongside the landmark Human Cytology Atlas, reflecting on decades of work in targeted organ-and-brain-specific regenerative medicine -- now validated by science. “To heal the brain, we must understand every cell within it,” he says, reaffirming his long-held belief in precision-targeted therapy.
Prof. Mike Chan reviews a brain replica alongside the landmark Human Cytology Atlas, reflecting on decades of work in targeted organ-and-brain-specific regenerative medicine -- now validated by science. “To heal the brain, we must understand every cell within it,” he says, reaffirming his long-held belief in precision-targeted therapy.

The landmark Human Cytology Atlas utilized single-cell RNA sequencing, high-dimensional cytometry, and bioinformatics to classify and quantify human cell types across various organs — including the intricate human brain. This cellular roadmap redefines how therapies must be developed: not generically, but tailored to match specific cell populations within targeted organs.

"While precision medicine has gained widespread recognition, I have always believed that true healing demands an even deeper understanding — acknowledging that every stem cell is inherently unique.

Each of the 400+ human cell types carries distinct molecular blueprints, comprising specific molecules, amino acid sequences, proteins, glycation rates, and transcription factors, all intricately tailored to the organs and tissues they sustain.

This principle has been the cornerstone of my work in developing targeted, brain-and-organ-specific-precursor stem cell bioregenerative therapies," said Prof. Dr. Mike Chan.

"For true regenerative success, A1 must match A1, B6 must match B6, Z10 must match Z10. There are no shortcuts when it comes to restoring the body's natural cellular balance."

The Brain: A Complex Frontier for Cellular Medicine

Among all organs, the brain exemplifies the need for cellular precision. As Prof. Chan noted, "To heal the brain, we must understand every cell within it." The Human Cytology Atlas revealed extraordinary specialization within brain structures such as the frontal lobe, hippocampus, pineal gland, prefrontal cortex, and substantia nigra. Each region contains unique cell types with distinct roles, underlining why regenerative therapies must match the exact cells to the corresponding brain area [2].

Prof. Chan's protocols at European Wellness emphasize this targeted strategy:

  • Frontal lobe neurons for Alzheimer's disease
  • Prefrontal cortex cells for autism
  • Pineal gland cells for sleep disorders
  • Hippocampal neurons for memory and emotional balance
  • Substantia nigra cells for Parkinson's disease

The Atlas's validation of cell diversity confirms that brain regeneration requires organ-specific, cell-specific therapies — reinforcing European Wellness' pioneering approach.

5 Key Breakthroughs from the Human Cytology Study

  1. Over 400 Cell Types Classified: First-ever complete catalog of human cell types with defined biological roles.
  2. Quantitative Mapping of Cells by Organ: Precision data on cell numbers and distribution enables anatomically tailored therapies.
  3. Discovery of Rare Functional Subtypes: New therapeutic targets for repair, immunity, and neuro-regeneration uncovered.
  4. Validation of Organ-Specific Cellular Identity: Proves that stem cells must be matched specifically to organ and tissue type.
  5. Recognition of Variable Regenerative Capacities: Enables smarter, prioritized treatment designs for aging and chronic diseases.

European Wellness: Precision Medicine in Action

For the first time, regenerative medicine has an exact cellular blueprint to follow. Instead of relying on generalized interventions, clinicians can now design therapies that match organ structure and cellular identity — fulfilling a vision Prof. Mike Chan and European Wellness have advocated for over four decades.

European Wellness Biomedical Group continues to be at the forefront of precision regenerative medicine. Through targeted organ-and-brain-specific precursor stem cell therapies, they deliver individualized programs targeting liver disease, cardiac conditions, neurodegenerative disorders, and memory restoration.

References:

[1] Chan MKS, Jambo SA, Jumat MI, Landa F, Saili NS, et al. Human Cytology: Classification and Quantitative Cell Landscape with Numbers, Types and Functional Diversity. J Stem Cell Res. 6(1):1-42.

[2] Mike KS Chan, Mohd Iskandar Jumat*, Florisa Landa, Nur Shafawati Saili, Siti Azmah Jambo, et al. Exploring the Complexity of the Human Brain: Cell Types, Numbers, and Lobar Functions. Am J Biomed Sci & Res. 2025 26(4) AJBSR.MS.ID.003452, 

About European Wellness Biomedical Group

European Wellness is an award-winning biomedical group specializing in advanced targeted organ-and-brain-specific precursor stem cell therapy, anti-aging, and regenerative protocols. The Group operates flagship centers in Germany, Switzerland, Greece, Malaysia and all over Asia.

Photo - https://mma.prnewswire.com/media/2678608/Prof_Mike_Chan_reviews_a_brain_replica_landmark_Human_Cytology.jpg

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Prof. Mike Chans Vision der Präzisionsmedizin wird durch eine bahnbrechende Humanzytologie-Studie bestätigt, die über 400 verschiedene Zelltypen kartiert, mit besonderem Schwerpunkt auf dem Gehirn

Prof. Mike Chans Vision der Präzisionsmedizin wird durch eine bahnbrechende Humanzytologie-Studie bestätigt, die über 400 verschiedene Zelltypen kartiert, mit besonderem Schwerpunkt auf dem Gehirn

Eine bahnbrechende internationale Studie hat über 400 verschiedene menschliche Zelltypen kartiert und damit Prof. Mike Chans langjährige Vision einer ...

La vision de la médecine de précision du professeur Mike Chan est validée par une étude cytologique humaine historique qui cartographie plus de 400 types cellulaires distincts, en particulier dans le cerveau.

La vision de la médecine de précision du professeur Mike Chan est validée par une étude cytologique humaine historique qui cartographie plus de 400 types cellulaires distincts, en particulier dans le cerveau.

Une étude internationale révolutionnaire a permis de cartographier plus de 400 types cellulaires distincts dans le corps humain, validant ainsi la...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Biotechnology

Biotechnology

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.